Search Funding Opportunities

Search by category

Pfizer: Inflammatory and Immune-Mediated Dermatologic Disorders Research

Grant Amount: Up to $175,000
Deadline: February 24, 2021
Category: Health Sciences; Dermatology,
Additional Information

Pfizer has issued an RFP for Inflammatory and Immune-Mediated Dermatologic Disorders research.

Through the RFP, grants of up to $175,000 will be awarded in support of preclinical, clinical, and outcomes research with the intent to increase medical knowledge in the diagnosis and management of inflammatory and immune-mediated dermatologic disorders. Areas of research focus include mechanistic insights into the role of the JAK/STAT pathway in inflammatory dermatologic diseases; pharmacogenomic studies in atopic dermatitis to identify potential responders to JAK inhibition, including skin color; unmet need and burden of disease of alopecia areata and vitiligo; epidemiological studies in alopecia areata; validation of AD disease severity measures in skin of color; identification of inflammatory pathways related to the pathophysiology of alopecia areata and vitiligo; and identification of immunophenotypic differences in clinical course and treatment response of AD in skin of color.

To be eligible, applicants must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in pharmacy, physiotherapy, or social work. The institution and principal investigator (PI) must be based in the U.S.

See the Pfizer website for complete program guidelines and application instructions.

Learn More